FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1813330621> ?p ?o ?g. }

• W1813330621 endingPage "214" @default.
• W1813330621 startingPage "206" @default.
• W1813330621 abstract "Nephrotic syndrome (NS) develops most commonly in people with glomerular diseases associated with marked albuminuria. Hypernatremia, hypertension, and progressive renal failure are more prevalent in nephrotic than nonnephrotic human patients.Dogs with NS have higher serum cholesterol, triglyceride, and sodium concentrations, higher urine protein:creatinine ratios (UPC) and systolic blood pressure, and lower serum albumin concentrations than dogs with nonnephrotic glomerular disease (NNGD). NS is associated with membranous glomerulopathy and amyloidosis. Affected dogs are more likely to be azotemic and have shorter survival times.Two hundred and thirty-four pet dogs (78 NS dogs, 156 NNGD dogs).Multicenter retrospective case-control study comparing time-matched NS and NNGD dogs. NS was defined as the concurrent presence of hypoalbuminemia, hypercholesterolemia, proteinuria, and extravascular fluid accumulation. Signalment, clinicopathologic variables, histopathologic diagnoses, and survival time were compared between groups.Age, serum albumin, chloride, calcium, phosphate, creatinine, and cholesterol concentrations, and UPC differed significantly between NS and NNGD dogs. Both groups were equally likely to be azotemic at time of diagnosis, and NS was not associated with histologic diagnosis. Median survival was significantly shorter for NS (12.5 days) versus NNGD dogs (104.5 days). When subgrouped based on serum creatinine (< or ≥1.5 mg/dL), survival of NS versus NNGD dogs was only significantly different in nonazotemic dogs (51 versus 605 days, respectively).Presence of NS is associated with poorer prognosis in dogs with nonazotemic glomerular disease. Preventing development of NS is warranted; however, specific interventions were not evaluated in this study." @default.
• W1813330621 created "2016-06-24" @default.
• W1813330621 creator A5005425574 @default.
• W1813330621 creator A5009992750 @default.
• W1813330621 creator A5011561379 @default.
• W1813330621 creator A5013569213 @default.
• W1813330621 creator A5028826503 @default.
• W1813330621 creator A5032841847 @default.
• W1813330621 creator A5044185819 @default.
• W1813330621 creator A5053071494 @default.
• W1813330621 creator A5064996823 @default.
• W1813330621 creator A5065273674 @default.
• W1813330621 creator A5066785782 @default.
• W1813330621 creator A5068438813 @default.
• W1813330621 creator A5086028336 @default.
• W1813330621 date "2011-01-31" @default.
• W1813330621 modified "2023-10-17" @default.
• W1813330621 title "Comparison of Signalment, Clinicopathologic Findings, Histologic Diagnosis, and Prognosis in Dogs with Glomerular Disease with or without Nephrotic Syndrome" @default.
• W1813330621 cites W1964920299 @default.
• W1813330621 cites W1974318560 @default.
• W1813330621 cites W1976089771 @default.
• W1813330621 cites W1982135746 @default.
• W1813330621 cites W1990893785 @default.
• W1813330621 cites W2024751872 @default.
• W1813330621 cites W2027322822 @default.
• W1813330621 cites W2034907048 @default.
• W1813330621 cites W2036563690 @default.
• W1813330621 cites W2053979221 @default.
• W1813330621 cites W2054040672 @default.
• W1813330621 cites W2064894507 @default.
• W1813330621 cites W2098044786 @default.
• W1813330621 cites W2127008793 @default.
• W1813330621 cites W2286009284 @default.
• W1813330621 cites W2325131581 @default.
• W1813330621 cites W4231170119 @default.
• W1813330621 cites W4232219229 @default.
• W1813330621 doi "https://doi.org/10.1111/j.1939-1676.2010.0669.x" @default.
• W1813330621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21281353" @default.
• W1813330621 hasPublicationYear "2011" @default.
• W1813330621 type Work @default.
• W1813330621 sameAs 1813330621 @default.
• W1813330621 citedByCount "29" @default.
• W1813330621 countsByYear W18133306212012 @default.
• W1813330621 countsByYear W18133306212013 @default.
• W1813330621 countsByYear W18133306212015 @default.
• W1813330621 countsByYear W18133306212016 @default.
• W1813330621 countsByYear W18133306212017 @default.
• W1813330621 countsByYear W18133306212018 @default.
• W1813330621 countsByYear W18133306212019 @default.
• W1813330621 countsByYear W18133306212020 @default.
• W1813330621 countsByYear W18133306212021 @default.
• W1813330621 countsByYear W18133306212022 @default.
• W1813330621 countsByYear W18133306212023 @default.
• W1813330621 crossrefType "journal-article" @default.
• W1813330621 hasAuthorship W1813330621A5005425574 @default.
• W1813330621 hasAuthorship W1813330621A5009992750 @default.
• W1813330621 hasAuthorship W1813330621A5011561379 @default.
• W1813330621 hasAuthorship W1813330621A5013569213 @default.
• W1813330621 hasAuthorship W1813330621A5028826503 @default.
• W1813330621 hasAuthorship W1813330621A5032841847 @default.
• W1813330621 hasAuthorship W1813330621A5044185819 @default.
• W1813330621 hasAuthorship W1813330621A5053071494 @default.
• W1813330621 hasAuthorship W1813330621A5064996823 @default.
• W1813330621 hasAuthorship W1813330621A5065273674 @default.
• W1813330621 hasAuthorship W1813330621A5066785782 @default.
• W1813330621 hasAuthorship W1813330621A5068438813 @default.
• W1813330621 hasAuthorship W1813330621A5086028336 @default.
• W1813330621 hasConcept C126322002 @default.
• W1813330621 hasConcept C134018914 @default.
• W1813330621 hasConcept C159641895 @default.
• W1813330621 hasConcept C165616093 @default.
• W1813330621 hasConcept C2776009029 @default.
• W1813330621 hasConcept C2776174234 @default.
• W1813330621 hasConcept C2778415529 @default.
• W1813330621 hasConcept C2778930706 @default.
• W1813330621 hasConcept C2779561371 @default.
• W1813330621 hasConcept C2780091579 @default.
• W1813330621 hasConcept C2780306776 @default.
• W1813330621 hasConcept C71924100 @default.
• W1813330621 hasConcept C90924648 @default.
• W1813330621 hasConceptScore W1813330621C126322002 @default.
• W1813330621 hasConceptScore W1813330621C134018914 @default.
• W1813330621 hasConceptScore W1813330621C159641895 @default.
• W1813330621 hasConceptScore W1813330621C165616093 @default.
• W1813330621 hasConceptScore W1813330621C2776009029 @default.
• W1813330621 hasConceptScore W1813330621C2776174234 @default.
• W1813330621 hasConceptScore W1813330621C2778415529 @default.
• W1813330621 hasConceptScore W1813330621C2778930706 @default.
• W1813330621 hasConceptScore W1813330621C2779561371 @default.
• W1813330621 hasConceptScore W1813330621C2780091579 @default.
• W1813330621 hasConceptScore W1813330621C2780306776 @default.
• W1813330621 hasConceptScore W1813330621C71924100 @default.
• W1813330621 hasConceptScore W1813330621C90924648 @default.
• W1813330621 hasIssue "2" @default.
• W1813330621 hasLocation W18133306211 @default.
• W1813330621 hasLocation W18133306212 @default.
• W1813330621 hasOpenAccess W1813330621 @default.
• W1813330621 hasPrimaryLocation W18133306211 @default.

• next